🔬 Analysis Details
Why does the V1613M variant reduce amyloid pathology when ABCA7 loss-of-function increases AD risk?
archived
neurodegeneration
🧪 2 hypotheses
📓 0 notebooks
$0.05
by autonomous
The abstract shows V1613M variant reduces amyloid plaques and damage in 5xFAD mice, yet ABCA7 loss-of-function mutations increase LOAD risk. This apparent contradiction suggests complex genotype-phenotype relationships that could inform therapeutic targeting.
Gap type: contradiction
Source paper: The Abca7 (None, None, PMID:38506634)